个性化文献订阅>期刊> Cancer gene therapy
 

TNF-alpha and the IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma

  作者 Enderlin, M; Kleinmann, EV; Struyf, S; Buracchi, C; Vecchi, A; Kinscherf, R; Kiessling, F; Paschek, S; Sozzani, S; Rommelaere, J; Cornelis, JJ; Van Damme, J; Dinsart, C  
  选自 期刊  Cancer gene therapy;  卷期  2009年16-2;  页码  149-160  
  关联知识点  
 

[摘要]Interferon-gamma-inducible protein 10 is a potent chemoattractant for natural killer cells and activated T lymphocytes. It also displays angiostatic properties and some antitumor activity. Tumor necrosis factor-alpha (TNF-alpha) is a powerful immunomodulating cytokine with demonstrated tumoricidal activity in various tumor models and the ability to induce strong immune responses. This prompted us to evaluate the antitumor effects of recombinant parvoviruses designed to deliver IP-10 or TNF-alpha into a glioblastoma. When Gl261 murine glioma cells were infected in vitro with an IP-10- or TNF-alpha-transducing parvoviral vector and were subcutaneously implanted in mice, tumor growth was significantly delayed. Complete tumor regression was observed when the glioma cells were coinfected with both the vectors, demonstrating synergistic antitumor activity. In an established in vivo glioma model, however, repeated simultaneous peritumoral injection of the IP-10- and TNF-alpha-delivering parvoviruses failed to improve the therapeutic effect as compared with the use of a single cytokine-delivering vector. In this tumor model, cytokine-mediated immunostimulation, rather than inhibition of vascularization, is likely responsible for the therapeutic efficacy.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内